There is an international line-up of speakers at EuroSciCon's 'ELISPOT technology: Newer tricks' meeting on 8th July 2008 at BioPark Hertfordshire. This CPD accredited meeting will discuss the advances made in ELISPOT technology including the range of cytokines that can be measured, as well discussions on assay development and applications to both basic and clinical research.
The Chair Dr Sefina Arif (Kings College, London) says, "ELISPOT technology will cover all aspects of the assay development from initial cell stimulation to analyzing spot formation".
Speakers include:
'ELISpot applications in type 1 diabetes and other autoimmune diseases'. Dr Roberto Mallone, (Hopital Saint Vincent de Paul, France)
Multicolour analysis and standardization of ELISPOT for clinical trials Professor Paul Lehmann, Professor of Pathology at Case Western Reserve University, USA
Professor Ajit Lalvani, Head, Tuberculosis Immunology Group, National Heart and Lung Institute, UK
Cytokine ELISPOT technology: A 'tricky' business Dr Peter Vander Meide, U-CyTech biosciences, The Netherlands
Quality management at Pharma industry level, applied to Elispot Readers. Dr Werner Freber, CEO and founder of BIO-SYS GmbH, Germany
Dr Huriya Beyan, Queen Mary, University of London, UK
Fluorospot - fluorochrome-based detection of cytokine-producing cells Assoc. Professor Niklas Ahlborg, Mabtech AB, Sweden
To book, please visit www.regonline.com/elispot08 . The deadline for early registration is April 20th 2008.
There is still time to submit an abstract - those accepted for poster and oral presentations will also be published in the proceedings. There will be a prize for the best poster. Abstract guidelines can be found at http://www.euroscicon.com/absguidlines.html
